The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...

The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.

We conducted our study at 2 baby-oriented health fairs open to the public in Los Angeles County (Long Beach and Torrance), California, during September and November 2006. All study procedures were ...

The initial container systems will include 0.5 mL, 1 mL long, and 1 mL short syringes, along with 2R vials ... and proven focus on manufacturing APIs, oral solid dose, and liquid dosage forms ...

The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...

Penile nerve blocks, local anesthetics, various operative instruments, acetaminophen, sweet oral solutions ... circumcision pain (Fig 1). Mix 15 g of table sugar in 60 mL of sterile water to ...

1 School of Clinical Medicine ... 5.0 ml calibrated spoon and 5.0 ml oral syringe. Samples were weighed and converted to mls. Main outcome measures The mean volume and variance of volumes were ...

Abilify oral tablet ... single-dose syringes. Abilify Maintena comes in two strengths: 300 mg and 400 mg. Abilify Asimtufii comes in two strengths: 960 mg per 3.2 milliliters (mL) and 720 mg ...